Collins stated that allowing recess appointments without Senate approval would circumvent the constitutional duty of 'advice and consent,' impacting oversight of health agency appointments.
She emphasized the importance of thorough vetting for nominees, which should involve 'extensive committee investigations and questionnaires and public hearings,' to ensure responsible leadership.
Collins expressed concern over potential significant changes at NIH and FDA due to Trump's appointees, highlighting the implications of Kennedy and Oz's health policy perspectives.
Cassidy praised Oz for his past advocacy on public health topics, like transparency and healthy foods, while maintaining an open attitude towards Kennedy's nomination.
Collection
[
|
...
]